Catalyst Wire Dossier Catalyst Wire Dossier

Lisinopril/Hydrochlorothiazide tablets (20 mg/25 mg)

lisinopril/hydrochlorothiazide
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lisinopril/Hydrochlorothiazide tablets (20 mg/25 mg), covering 2013-04-15 to 2013-04-15. Get the full timeline:

Most recent: Clinical Trial Update: Bioequivalence Study of Lisinopril and Hydrochlorothiazide Tablets (20+25) mg Under Fasting Conditions [Phase 1]

See pricing